Buscar
Mostrando ítems 91-100 de 103
Artículo
Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment
(Aran Ediciones S.A., 2018)
Introduction: primary biliary cholangitis (PBC) is a rare disease with limited data regarding its epidemiology and standard clinical management in Spain. Objective: to gain insight into the epidemiology, patient f ...
Artículo
A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients
(Aran Ediciones S.A., 2017)
Objective: To evaluate the efficacy and safety of a quadruple regimen (BMTO) of the “3-in-1 capsule” (containing bismuth subcitrate potassium, metronidazole and tetracycline) plus omeprazole in naïve and previously ...
Artículo
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models
(Aran Ediciones S.A., 2019)
Introduction: non-alcoholic fatty liver disease is one of the most prevalent liver disorders in the developed world. Currently, there is no approved pharmacological therapy except for lifestyle intervention. Therefore, ...
Artículo
Evolution of the incidence of inflammatory bowel disease in Southern Spain
(Aran Ediciones S.A., 2017)
Background: The incidence of inflammatory bowel disease is increasing in Europe and in Spain. However, there is no recent data from Southern Spain. Objectives: To determine the evolution of the hospital incidence ...
Artículo
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
(Aran Ediciones S.A., 2019)
The Spanish Association for the Study of the Liver (AEEH) is convinced that the elimination of hepatitis C virus (HCV) in Spain is possible as long as we are able to use the re sources and tools necessary for it. This ...
Artículo
Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)
(Aran Ediciones S.A., 2019)
Background: recent evidence suggests a causal link between serum uric acid and the metabolic syndrome, dia betes me llitus, arterial hypertension, and renal and cardiac disease. Uric acid is an endogenous danger signal ...
Artículo
Overall clinical and economic impact of non-alcoholic fatty liver disease
(Aran Ediciones S.A., 2021)
Objectives: to establish the clinical and economic con sequences (resource utilization and healthcare costs) of non-alcoholic fatty liver in the setting of the usual clinical practice in Spain. Patients and methods: ...
Artículo
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
(Elsevier Science BV, 2021)
Background & Aims Prospective drug-induced liver injury (DILI) registries are important sources of information on idiosyncratic DILI. We aimed to present a comprehensive analysis of 843 patients with DILI enrolled into ...
Artículo
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease
(Elsevier, 2023)
Background & Aims: This study assessed the effects of the glucagon-like peptide-1 (GLP-1)/glucagon receptor co-agonist efinopegdutide relative to the selective GLP-1 receptor agonist semaglutide on liver fat content (LFC) ...
Artículo
Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver
(Aran Ediciones S.A., 2023)
Back in January 2022, a The Lancet-European Association for the Study of the Liver (EASL) Commission on the impact of liver disorders in the European region commissioned by the World Health Organization (WHO) ...